Pyridam Farma Tbk PT banner

Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 410 IDR 4.59% Market Closed
Market Cap: Rp4.6T

Pyridam Farma Tbk PT
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pyridam Farma Tbk PT
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
EPS (Diluted)
-Rp45
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
EPS (Diluted)
Rp331
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
10%
Kalbe Farma Tbk PT
IDX:KLBF
EPS (Diluted)
Rp76
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
6%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
EPS (Diluted)
Rp154
CAGR 3-Years
58%
CAGR 5-Years
-2%
CAGR 10-Years
5%
Soho Global Health Tbk PT
IDX:SOHO
EPS (Diluted)
Rp36
CAGR 3-Years
-6%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
EPS (Diluted)
-Rp357
CAGR 3-Years
-122%
CAGR 5-Years
-158%
CAGR 10-Years
N/A
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
4.6T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
HIDDEN
Show

See Also

What is Pyridam Farma Tbk PT's EPS (Diluted)?
EPS (Diluted)
-45.4 IDR

Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's EPS (Diluted) amounts to -45.4 IDR.

What is Pyridam Farma Tbk PT's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
-101%

Over the last year, the EPS (Diluted) growth was -101%.

Back to Top